Search Results - "Hikichi, Hirohiko"
-
1
Targeting of metabotropic glutamate receptors for the treatment of schizophrenia
Published in Current pharmaceutical design (2011)“…The glutamatergic system is involved in a wide range of physiological processes in the brain, and its dysfunction plays an important role in the etiology and…”
Get more information
Journal Article -
2
Stimulation of Metabotropic Glutamate (mGlu) 2 Receptor and Blockade of mGlu1 Receptor Improve Social Memory Impairment Elicited by MK-801 in Rats
Published in Journal of Pharmacological Sciences (2013)“…Glutamatergic dysfunction has been implicated in psychiatric disorders such as schizophrenia. Both the stimulation of the metabotropic glutamate (mGlu) 2/3…”
Get full text
Journal Article -
3
Stimulation of postsynapse adrenergic α2A receptor improves attention/cognition performance in an animal model of attention deficit hyperactivity disorder
Published in Behavioural brain research (15-08-2014)“…•Clonidine improved attention deficit in the 5-trial inhibitory avoidance model.•Guanfacine improved attention deficit in the 5-trial inhibitory avoidance…”
Get full text
Journal Article -
4
Discovery and in vitro and in vivo profiles of 4-fluoro- N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]- N-methylbenzamide as novel class of an orally active metabotropic glutamate receptor 1 (mGluR1) antagonist
Published in Bioorganic & medicinal chemistry letters (15-09-2009)“…We identified 4-fluoro- N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]- N-methylbenzamide 27 as a potent mGluR1 antagonist. The compound possessed…”
Get full text
Journal Article -
5
Antipsychotic profiles of TASP0443294, a novel and orally active positive allosteric modulator of metabotropic glutamate 2 receptor
Published in Journal of pharmacological sciences (01-03-2015)“…Glutamatergic dysfunction has been implicated in psychiatric disorders such as schizophrenia. The stimulation of metabotropic glutamate (mGlu) 2 receptor has…”
Get full text
Journal Article -
6
Preclinical metabolism and the disposition of vornorexant/TS‐142, a novel dual orexin 1/2 receptor antagonist for the treatment of insomnia
Published in Pharmacology research & perspectives (01-04-2024)“…We investigated the metabolism and disposition of vornorexant, a novel dual orexin receptor antagonist, in rats and dogs, and clarified in vitro metabolite…”
Get full text
Journal Article -
7
Behavioral effects of N -desmethylclozapine on locomotor activity and sensorimotor gating function in mice—Possible involvement of muscarinic receptors
Published in Brain research (18-10-2011)“…Abstract N -desmethylclozapine (NDMC), a major circulating metabolite of the atypical antipsychotic drug, clozapine, and has M1 muscarinic receptor partial…”
Get full text
Journal Article -
8
Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide]
Published in The Journal of pharmacology and experimental therapeutics (01-08-2008)“…The functional roles of metabotropic glutamate receptor (mGluR) 1 in integrative brain functions were investigated using a potent and selective mGluR1…”
Get more information
Journal Article -
9
Discovery and biological profile of isoindolinone derivatives as novel metabotropic glutamate receptor 1 antagonists: A potential treatment for psychotic disorders
Published in Bioorganic & medicinal chemistry letters (15-09-2009)“…We describe here the discovery and biological profile of a series of isoindolinone derivatives as developed mGluR1 antagonists. Our combined strategy of rapid…”
Get full text
Journal Article -
10
Unique antipsychotic activities of the selective metabotropic glutamate receptor 1 allosteric antagonist 2-cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-2,3-dihydro-1H-isoindol-1-one
Published in The Journal of pharmacology and experimental therapeutics (01-07-2009)“…A newly discovered metabotropic glutamate receptor (mGluR) 1 allosteric antagonist,…”
Get more information
Journal Article -
11
Characterization of metabolic phenotypes of mice lacking GPR61, an orphan G-protein coupled receptor
Published in Life sciences (1973) (21-11-2011)“…GPR61 is an orphan G protein-coupled receptor whose function remains unknown. The purpose of the present study is to elucidate the importance of GPR61 in…”
Get full text
Journal Article -
12
Antipsychotic effects of N-desmethylclozapine on sensorimotor gating function in rats — Possible involvement of activation of M₁ muscarinic receptors
Published in European journal of pharmacology (01-09-2011)“…N-desmethylclozapine (NDMC), one of the major metabolites of clozapine, has been demonstrated to exhibit partial agonistic activity at M₁ muscarinic receptors…”
Get full text
Journal Article -
13
Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC)
Published in The Journal of pharmacology and experimental therapeutics (01-06-2007)“…A highly potent and selective metabotropic glutamate receptor (mGluR) 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,…”
Get more information
Journal Article -
14
Correlation of Receptor Occupancy of Metabotropic Glutamate Receptor Subtype 1 (mGluR1) in Mouse Brain With In vivo Activity of Allosteric mGluR1 Antagonists
Published in Journal of Pharmacological Sciences (2009)“…The aim of this study was to clarify the relationship between receptor occupancy and In vivo pharmacological activity of mGluR1 antagonists. The tritiated…”
Get full text
Journal Article -
15
Face-washing behavior induced by the group I metabotropic glutamate receptor agonist (S)-3,5-DHPG in mice is mediated by mGlu1 receptor
Published in European journal of pharmacology (31-05-2008)“…It is known for the non-selective group I metabotropic glutamate (mGlu) receptors agonist (S)-3,5-dihydroxyphenylglycine (S-3,5-DHPG) to cause convulsions,…”
Get full text
Journal Article -
16
Safety and pharmacokinetic profiles of MGS0274 besylate (TS‐134), a novel metabotropic glutamate 2/3 receptor agonist prodrug, in healthy subjects
Published in British journal of clinical pharmacology (01-11-2020)“…Aims The safety and pharmacokinetics of single and multiple doses of a novel mGlu2/3 receptor agonist prodrug, MGS0274 besylate (TS‐134), were investigated in…”
Get full text
Journal Article -
17
A Novel Potent and Selective Histamine H 3 Receptor Antagonist Enerisant: In Vitro Profiles, In Vivo Receptor Occupancy, and Wake-Promoting and Procognitive Effects in Rodents
Published in The Journal of pharmacology and experimental therapeutics (01-11-2020)“…Histamine H receptor antagonists/inverse agonists are known to enhance the activity of histaminergic neurons in the brain, thereby promoting arousal and…”
Get full text
Journal Article -
18
Discovery of MGS0274, an ester prodrug of a metabotropic glutamate receptor 2/3 agonist with improved oral bioavailability
Published in European journal of medicinal chemistry (01-10-2020)“…We previously reported that MGS0008 is a selective group II metabotropic glutamate receptor (mGlu2/3 receptor) agonist that is effective in animal models of…”
Get full text
Journal Article -
19
Role of endogenous PACAP in catecholamine secretion from the rat adrenal gland
Published in American journal of physiology. Regulatory, integrative and comparative physiology (01-11-2001)“…We elucidated the contribution of endogenous pituitary adenylate cyclase-activating polypeptide (PACAP) to neurally evoked catecholamine secretion from the…”
Get more information
Journal Article -
20
Stimulation of the metabotropic glutamate (mGlu) 2 receptor attenuates the MK-801-induced increase in the immobility time in the forced swimming test in rats
Published in Pharmacological reports (01-02-2016)“…Negative symptoms of schizophrenia are poorly managed using the currently available antipsychotics. Previous studies indicate that agonists of the metabotropic…”
Get more information
Journal Article